Literature DB >> 6839542

Dynamics of mononuclear phagocyte system Fc receptor function in systemic lupus erythematosus. Relation to disease activity and circulating immune complexes.

R P Kimberly, T M Parris, R D Inman, J S McDougal.   

Abstract

Seventeen pairs of longitudinal studies of mononuclear phagocyte system (MPS) Fc receptor function in 15 patients with systemic lupus were performed to explore the dynamic range of Fc receptor dysfunction in lupus and to establish the relationships between MPS function, clinical disease activity and circulating immune complexes (CIC). Fc receptor function was measured by the clearance of IgG sensitized autologous erythrocytes. At the time of first study the degree of MPS dysfunction was correlated with both clinical activity (P less than 0.05) and CIC (P less than 0.05). At follow-up patients with a change in clinical status show significantly larger changes in clearance function compared to clinically stable patients (206 min vs 7 min; P less than 0.001). MPS function changed concordantly with a change in clinical status in all cases (P = 0.002). Longitudinal assessments did not demonstrate concordance of changes in MPS function and CIC, measured by three different assays. The MPS Fc receptor defect in systemic lupus is dynamic and closely associated with disease activity. The lack of concordance of the defect with changes in CIC suggests that either CIC does not adequately reflect receptor site saturation or that other factors may also contribute to the magnitude of MPS dysfunction.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6839542      PMCID: PMC1536877     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  29 in total

1.  Interpretation of the Raji cell assay in sera containing anti-nuclear antibodies and immune complexes.

Authors:  A C Horsfall; P J Venables; P A Mumford; R N Maini
Journal:  Clin Exp Immunol       Date:  1981-05       Impact factor: 4.330

2.  Immune complexes: a clinical perspective.

Authors:  R C Williams
Journal:  Am J Med       Date:  1981-11       Impact factor: 4.965

3.  Effects of soluble immune complexes on Fc receptor- and C3b receptor-mediated phagocytosis by macrophages.

Authors:  F M Griffin
Journal:  J Exp Med       Date:  1980-10-01       Impact factor: 14.307

4.  A serial study of splenic reticuloendothelial system Fc receptor functional activity in systemic lupus erythematosus.

Authors:  M I Hamburger; T J Lawley; R P Kimberly; P H Plotz; M M Frank
Journal:  Arthritis Rheum       Date:  1982-01

5.  In situ formation of subepithelial glomerular immune complexes in passive serum sickness.

Authors:  G Fleuren; J Grond; P J Hoedemaeker
Journal:  Kidney Int       Date:  1980-05       Impact factor: 10.612

6.  Correlation of DNA-anti-DNA association rates with clinical activity in systemic lupus erythematosus (SLE).

Authors:  L Pearson; R W Lightfoot
Journal:  J Immunol       Date:  1981-01       Impact factor: 5.422

7.  Mononuclear phagocytic system stimulation. Protective role from glomerular immune complex deposition.

Authors:  L Raij; R K Sibley; W F Keane
Journal:  J Lab Clin Med       Date:  1981-10

8.  Defective Fc-receptor functions associated with the HLA-B8/DRw3 haplotype: studies in patients with dermatitis herpetiformis and normal subjects.

Authors:  T J Lawley; R P Hall; A S Fauci; S I Katz; M I Hamburger; M M Frank
Journal:  N Engl J Med       Date:  1981-01-22       Impact factor: 91.245

9.  Raji cell assay for immune complexes. Evidence for detection of Raji-directed immunoglobulin G antibody in sera from patients with systemic lupus erythematosus.

Authors:  C L Anderson; W S Stillman
Journal:  J Clin Invest       Date:  1980-08       Impact factor: 14.808

10.  Modification of glomerular immune complex deposition in mice by activation of the reticuloendothelial system.

Authors:  U Barcelli; R Rademacher; Y M Ooi; B S Ooi
Journal:  J Clin Invest       Date:  1981-01       Impact factor: 14.808

View more
  12 in total

Review 1.  Diversity and duplicity: human FCgamma receptors in host defense and autoimmunity.

Authors:  Robert P Kimberly; Jianming Wu; Andrew W Gibson; Kaihong Su; Hongwe Qin; Xiaoli Li; Jeffrey C Edberg
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

2.  Activation of human monocytes via their sIgA receptors.

Authors:  S Padeh; C L Jaffe; J H Passwell
Journal:  Immunology       Date:  1991-02       Impact factor: 7.397

3.  Complement gene expression in hepatic and extrahepatic tissues of NZB and NZB x W (F1) mouse strains.

Authors:  J H Passwell; G F Schreiner; R A Wetsel; H R Colten
Journal:  Immunology       Date:  1990-10       Impact factor: 7.397

Review 4.  Complement deficiency and immune complex disease.

Authors:  K A Davies; J A Schifferli; M J Walport
Journal:  Springer Semin Immunopathol       Date:  1994

Review 5.  Fc receptor--more answers, more questions.

Authors:  L Fornůsek; V Vĕtvicka
Journal:  Folia Microbiol (Praha)       Date:  1984       Impact factor: 2.099

Review 6.  In vivo clearance by the mononuclear phagocyte system in humans: an overview of methods and their interpretation.

Authors:  C Halma; M R Daha; L A van Es
Journal:  Clin Exp Immunol       Date:  1992-07       Impact factor: 4.330

7.  Imaging and assessment of regional clearances of indium-111 labelled circulating immune complexes in humans.

Authors:  E Wirquin; C Bruneau; M Meignan; L Cinotti; A Sobel
Journal:  Eur J Nucl Med       Date:  1986

8.  Clearance of soluble aggregates of human immunoglobulin G in healthy volunteers and chimpanzees.

Authors:  S Lobatto; M R Daha; A A Voetman; J H Evers-Schouten; A A Van Es; E K Pauwels; L A Van Es
Journal:  Clin Exp Immunol       Date:  1987-07       Impact factor: 4.330

9.  The change in C3b receptors on erythrocytes from patients with systemic lupus erythematosus.

Authors:  K Yoshida; Y Yukiyama; S Hirose; T Miyamoto
Journal:  Clin Exp Immunol       Date:  1985-06       Impact factor: 4.330

10.  Fc gamma RIIA alleles are heritable risk factors for lupus nephritis in African Americans.

Authors:  J E Salmon; S Millard; L A Schachter; F C Arnett; E M Ginzler; M F Gourley; R Ramsey-Goldman; M G Peterson; R P Kimberly
Journal:  J Clin Invest       Date:  1996-03-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.